Dr Ma Cong (right), Associate Professor of the Department of Applied Biology and Chemical Technology
YnnoMed Limited, a PolyU startup co-founded by Dr Ma Cong, Associate Professor of the Department of Applied Biology and Chemical Technology, is going to partake in the BIO International Convention 2024 (BIO 2024) to be held next week in California. The convention is the largest and most comprehensive event for biotechnology in the world. The drug R&D startup has developed a new class of antibiotic drug candidates and obtained patents in the US, mainland China, Europe and Japan. Dr Ma said they target to obtain Food and Drug Administration accreditation for the new product, and to commence clinical trial in 2026.
Online coverage:
| SCMP | Hong Kong innovators look to world’s biggest biotech event in US to inject new life into projects | 27 May 2024 |
| Ming Pao Daily News | 疫後首赴美參展 中藥冀爭國際認證 港展館涵16生科公司 科技園：盼重上國際舞台 |
27 May 2024 |
